These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 9676834)

  • 21. p53 mutation and protein accumulation during multistage human esophageal carcinogenesis.
    Bennett WP; Hollstein MC; Metcalf RA; Welsh JA; He A; Zhu SM; Kusters I; Resau JH; Trump BF; Lane DP
    Cancer Res; 1992 Nov; 52(21):6092-7. PubMed ID: 1394236
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Different proliferative patterns characterize different preinvasive breast lesions.
    Viacava P; Naccarato AG; Bevilacqua G
    J Pathol; 1999 Jul; 188(3):245-51. PubMed ID: 10419590
    [TBL] [Abstract][Full Text] [Related]  

  • 23. p53 and p21 expression in precancerous lesions and carcinomas of the uterine cervix: overexpression of p53 predicts poor disease outcome.
    Huang LW; Chou YY; Chao SL; Chen TJ; Lee TT
    Gynecol Oncol; 2001 Nov; 83(2):348-54. PubMed ID: 11606096
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in the expression of matrix proteases and of the transcription factor c-Ets-1 during progression of precancerous bronchial lesions.
    Bolon I; Brambilla E; Vandenbunder B; Robert C; Lantuejoul S; Brambilla C
    Lab Invest; 1996 Jul; 75(1):1-13. PubMed ID: 8683934
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TabBO: a model reflecting common molecular features of androgen-independent prostate cancer.
    Navone NM; Rodriquez-Vargas MC; Benedict WF; Troncoso P; McDonnell TJ; Zhou JH; Luthra R; Logothetis CJ
    Clin Cancer Res; 2000 Mar; 6(3):1190-7. PubMed ID: 10741751
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of cyclins D1 and E is frequent in bronchial preneoplasia and precedes squamous cell carcinoma development.
    Lonardo F; Rusch V; Langenfeld J; Dmitrovsky E; Klimstra DS
    Cancer Res; 1999 May; 59(10):2470-6. PubMed ID: 10344760
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-grade dysplasia and superficial adenocarcinoma in Barrett's esophagus: histological mapping and expression of p53, p21 and Bcl-2 oncoproteins.
    Chatelain D; Fléjou JF
    Virchows Arch; 2003 Jan; 442(1):18-24. PubMed ID: 12536310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bax protein expression in colorectal cancer: association with p53, bcl-2 and patterns of relapse.
    Giatromanolaki A; Sivridis E; Stathopoulos GP; Fountzilas G; Kalofonos HP; Tsamandas A; Vrettou E; Scopa C; Polychronidis A; Simopoulos K; Koukourakis MI
    Anticancer Res; 2001; 21(1A):253-9. PubMed ID: 11299743
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of p53 in preneoplastic and early neoplastic bronchial lesions.
    Martin B; Verdebout JM; Mascaux C; Paesmans M; Rouas G; Verhest A; Ninane V; Sculier JP
    Oncol Rep; 2002; 9(2):223-9. PubMed ID: 11836584
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic significance of apoptosis in synovial sarcoma: correlation with clinicopathologic parameters, cell proliferative activity, and expression of apoptosis-related proteins.
    Kawauchi S; Fukuda T; Oda Y; Saito T; Oga A; Takeshita M; Yokoyama K; Chuman H; Iwamoto Y; Sasaki K; Tsuneyoshi M
    Mod Pathol; 2000 Jul; 13(7):755-65. PubMed ID: 10912935
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adenovirus-mediated expression of p53 or p21 in a papillary serous endometrial carcinoma cell line (SPEC-2) results in both growth inhibition and apoptotic cell death: potential application of gene therapy to endometrial cancer.
    Ramondetta L; Mills GB; Burke TW; Wolf JK
    Clin Cancer Res; 2000 Jan; 6(1):278-84. PubMed ID: 10656459
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential expressions of cyclin-dependent kinase inhibitors (p27 and p21) and their relation to p53 and Ki-67 in oral squamous tumorigenesis.
    Choi HR; Tucker SA; Huang Z; Gillenwater AM; Luna MA; Batsakis JG; El-Naggar AK
    Int J Oncol; 2003 Feb; 22(2):409-14. PubMed ID: 12527941
    [TBL] [Abstract][Full Text] [Related]  

  • 33. p53 mutants can often transactivate promoters containing a p21 but not Bax or PIG3 responsive elements.
    Campomenosi P; Monti P; Aprile A; Abbondandolo A; Frebourg T; Gold B; Crook T; Inga A; Resnick MA; Iggo R; Fronza G
    Oncogene; 2001 Jun; 20(27):3573-9. PubMed ID: 11429705
    [TBL] [Abstract][Full Text] [Related]  

  • 34. bcl2, p53 and bax in thyroid tumors and their relation to apoptosis.
    Farid P; Gomb SZ; Péter I; Szende B
    Neoplasma; 2001; 48(4):299-301. PubMed ID: 11712682
    [TBL] [Abstract][Full Text] [Related]  

  • 35. p53 apoptotic response to DNA damage dependent on bcl2 but not bax in head and neck squamous cell carcinoma lines.
    Crowe DL; Sinha UK
    Head Neck; 2006 Jan; 28(1):15-23. PubMed ID: 16302195
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of cell-cycle mediators in ovarian cancer cells after transfection with p16(INK4a), p21(WAF1/Cip-1), and p53.
    Ramirez PT; Gershenson DM; Tortolero-Luna G; Ramondetta LM; Fightmaster D; Wharton JT; Wolf JK
    Gynecol Oncol; 2001 Dec; 83(3):543-8. PubMed ID: 11733969
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of human p53 mutations with differential effects on the bax and p21 promoters using functional assays in yeast.
    Flaman JM; Robert V; Lenglet S; Moreau V; Iggo R; Frebourg T
    Oncogene; 1998 Mar; 16(10):1369-72. PubMed ID: 9546439
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sebaceous carcinoma. Tumor progression through mutational inactivation of p53.
    Gonzalez-Fernandez F; Kaltreider SA; Patnaik BD; Retief JD; Bao Y; Newman S; Stoler MH; Levine PA
    Ophthalmology; 1998 Mar; 105(3):497-506. PubMed ID: 9499782
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Initiation of human astrocytoma by clonal evolution of cells with progressive loss of p53 functions in a patient with a 283H TP53 germ-line mutation: evidence for a precursor lesion.
    Fulci G; Ishii N; Maurici D; Gernert KM; Hainaut P; Kaur B; Van Meir EG
    Cancer Res; 2002 May; 62(10):2897-905. PubMed ID: 12019170
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deletions of 17p and p53 mutations in preneoplastic lesions of the lung.
    Sozzi G; Miozzo M; Donghi R; Pilotti S; Cariani CT; Pastorino U; Della Porta G; Pierotti MA
    Cancer Res; 1992 Nov; 52(21):6079-82. PubMed ID: 1394234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.